• Zacks Investment Research recently raised its forecast for SRAX’s 4Q21 revenues to $10.05mn, representing +122.3% YoY growth
• Zacks have also upped their fiscal year 2022 revenue forecast to $42.52 million, implying +35% YoY growth
• SRAX’s implied results look even more impressive given that it will no longer be consolidating the financials of key subsidiary, BIGtoken, following the latter company’s merger with BritePool, Inc
• SRAX’s future growth trajectory is set to be dictated by investor intelligence platform, Sequire, having recently recorded its twelfth consecutive quarter of revenue growth

SRAX (NASDAQ: SRAX) a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has seen its financial performance go from strength to strength over the past year. SRAX recently reported its third quarter results on November 15th, 2021, revealing third quarter revenues of $8.3 million, a figure which was up 219% year-over-year and 8% on a quarter-over-quarter basis. Zacks Investment Research, an American independent research and investment content advisory, has recently published its forecast for the upcoming quarter, projecting SRAX to report $10.05 million in sales for the current fiscal quarter. SRAX reported sales of $4.52 million over the same quarter last year, which would imply a theoretical year over year growth rate of 122.3%. SRAX is expected to publish its fourth quarter results on Monday, April 4th, 2022 (https://ibn.fm/HnE2o). According to the analysts at Zacks Investment Research, SRAX is expected to report full year sales of $31.48 million for the current fiscal year, with current analyst estimates ranging from $31.43 million to $31.53 million. Meanwhile and for 2022, Zacks expects SRAX to report sales of $42.52 million. SRAX’s large growth trajectory looks even more impressive in light of the news that the company will no longer consolidate the financials for its former subsidiary, BIGtoken, Inc following the latter company’s merger with BritePool, Inc; both companies formally announced the completion of their merger as of December 2, 2021, with the combined entity changing its corporate name to BIGtoken, Inc. Rather, SRAX will continue to hold a BIGtoken position on their balance sheet valued at nearly $4 million, with the carrying value of the equity set to be adjusted on a quarterly basis to mark the position to market. SRAX’s future growth will be driven by Sequire, SRAX’s investor intelligence platform, with Sequire having reported 3Q21 bookings of $8.9 million with Q4 set to rise to a record $12.5 million as of date. SRAX management revealed that they were projecting a further $4 million in Sequire bookings during the fourth quarter, a target which would drive the division’s total booked revenue in Q4 to $16.5 million and extend a run which has seen Sequire report twelve consecutive quarters of revenue growth. Christopher Miglino, Founder and CEO of SRAX elaborated on the results, “Our team continues to innovate on product, sales, and marketing; and this is translating into increased revenue. We will hit the high end of our 2021 guidance and are well positioned to close out 2021 strong, with an amazing 2022 on the horizon.” SRAX’s impressive results and growth trajectory have also played a significant role in bolstering its shareholder register, with several hedge funds and other institutional investors having recently added to their stakes in the business. BlackRock Inc. raised its stake in SRAX by 3.9% during the 3rd quarter, with the asset manager now possessing 70,504 shares of the business services provider’s stock worth $377,000 after acquiring an additional 2,653 shares during the period. Northern Trust Corp raised its stake in SRAX by 16.5% during the 2nd quarter, taking its stake up to 37,199 shares of the business services provider’s stock worth $202,000 after acquiring an additional 5,267 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in SRAX by 8.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 93,283 shares of the business services provider’s stock worth $507,000 after acquiring an additional 7,400 shares during the period. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• PlantX Life Inc. is an e-commerce retailer devoted to not only selling plant products, but educating consumers about their effective use and wellness benefits
• The company has developed a weekly podcast series, YouTube channel videos and an active blog to provide information about the plant-based ecosystem
• Global thought leaders concerned about climate change are signaling the role traditional meat production plays in concerns about the planet’s environment, ranging from methane production to deforestation issues
• Concerns about effective food production and climate sustainability also point to the conflicts and wars that inevitably arise from national insecurity
• Consumers who identify themselves as vegan or largely interested in plant-based products are a rapidly growing sector of the food market, creating a need for an information hub such as that developed by PlantX Life

When world political leaders and influencers gathered for The 2021 United Nations Climate Change Conference, more commonly referred to as COP26, in October and November, concerns about how to abandon fossil fuel technologies in favor of fuels with a less-polluting, climate-sustaining footprint captured media attention. But another significant emerging concern among many of the nations is food sustainability as the earth’s climate grows hotter.

“Food security is national security,” former deputy assistant secretary of defense Matt Spence, a senior official at the National Security Council (“NSC”), stated in a recent opinion editorial for Slate that argues for the importance of adopting plant-based meats and lab-grown, animal cell-based meats as alternatives to current meat-based lifestyles (https://ibn.fm/jORZv).

“Already, countries are facing the first famines caused by climate change. While heading up Middle East policy at the Pentagon, I saw how ISIS leveraged drought and crop failures to win the support of vulnerable populations and expand its reach,” Spence stated. “Industrialized agriculture is a greater contributor to methane emissions than any other source. Meat is the top contributor to deforestation. … Per pound, conventional meat production produces more than 10 times as much air pollution and more than six times as much toxic chemicals as plant-based meat. A 2018 study suggests that replacing a chicken patty with a plant-based alternative could reduce emissions by two-thirds.”

Spence concluded that eating less industrially farmed meat will be good for the planet and help nations avoid the war and conflict that follow food pressures brought on by industrialized agriculture-caused climate change.

Plant-based lifestyle e-retailer PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is working to position itself at the forefront of efforts to adopt a plant-based, alternative protein-based lifestyle that not only promotes nutritional health, but overall well-being through connectivity to the earth’s natural resources and efforts to sustain them. And in keeping with Spence’s observations, plant-based living could help promote national security.

PlantX Life aims to be a one-stop shopping source for plant-based products as well as for information that educates consumers about how to pursue and enjoy a plant-based lifestyle. Worldwide, an estimated 2 billion people live primarily on a meat-based diet, while an estimated 4 billion live primarily on a plant-based diet, a 2003 report for The American Journal of Clinical Nutrition noted (https://ibn.fm/hIJVn).

In the United States, a separate report found a 500 percent increase in consumers who state they are vegan between 2014 and 2017, and an 11 percent increase in retail sales of plant-based foods between 2018 and 2019 (https://ibn.fm/LuqAD).

The statistics indicate a steady market for the plant-based lifestyle, as well as a need for resources to sustain newcomers’ efforts to adopt such a lifestyle. PlantX’s educational strategy includes a weekly podcast, blog and YouTube presence that provide an abundance of tips on healthy diet choices, plant-growing wisdom and how to fit into the growing vegan community.

During the past year, the company also began employing the power of social media “micro-influencers” to advance the PlantX brand and widen the potential for plant-based wellness adoption.

“PlantX is always looking to adopt the most effective and impactful marketing strategies and leveraging the power of social media is a crucial component of our marketing efforts,” PlantX founder Sean Dollinger stated when the strategy was announced in November (https://ibn.fm/7P8Ew).

For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• Best Startup Canada named BevCanna Enterprises one of the 101 Top Food and Beverage Startups and Companies in Canada
• BevCanna was also recognized as one of the Top 101 Cannabis Startups in the country
• The company has had strong growth momentum in its core business, with 3Q21 revenues rising over 1,000% year-over-year
• BevCanna signed an agreement to manufacture and white-label cannabis beverages on behalf of Averi Health Products, which will subsequently be distributed in the Canadian market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) — a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients — announced that it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada, a media company that focuses on the latest innovations, breakthroughs and greatest companies across Canada (https://ibn.fm/vwGbE). Ranging from cutting-edge startups to established brands within the food and beverage sector, the companies recognized on the prestigious Top 101 list are known for both their innovation within their field as well as their exceptional growth and social impact. “It’s both an honor and a reflection of the BevCanna team’s expertise and dedication to be included within the sphere of other premier Canadian food and beverage companies, including Ritual, Goodfood, Flow Water, Chef’s Plate and David’s Tea,” noted Marcello Leone, CEO of BevCanna. “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy of developing innovative, highly-customized beverage products that appeal to a range of target markets, including value, craft and premium positioning, for both our in-house brands and our white-label clients.” In addition to being selected to the 101 Top Food and Beverage list, BevCanna was also recognized as being part of the Top 101 Cannabis Startups and Companies in Canada, a list of innovators and growth companies within the Canadian cannabis industry. BevCanna Enterprises’ recent accolades come amidst a period of strong ongoing growth momentum for the company, most aptly illustrated through BevCanna’s strong third quarter earnings report, with the company revealing that it witnessed revenues rise by upwards of 1,000 percent to $1.1 million over the quarter. BevCanna Enterprises has seen its commercial prospects go from strength to strength as it worked towards broadening its product portfolio, having just entered into an agreement to manufacture and white-label cannabis beverages for Averi Health Products (https://ibn.fm/KcZfb), an emerging beverage company seeking to formulate sophisticated cocktails that replicate the flavor profile of some of the world’s most traditional and best-selling cocktails, while boasting zero alcohol content. The Averi announcement follows on from similar deals, with BevCanna signing agreements with The Tinley Beverage Company (CSE: TNU) (OTCQX: TNYBF), Keef Brands and Xebra Brand Ltd (CSE: XBRA) (OTC: XBRAF) (FSE: 9YC) over the past several months for the manufacture of its respective products for distribution within the Canadian market. To that end and to further its distribution footprint within the nation, BevCanna’s Naturo Group announced that it had finalized an agreement with leading North American wholesale distributor, United Natural Foods (NYSE: UNFI). Pursuant to the agreement, UNFI Canada will carry and distribute BevCanna’s TRACE line of products, resulting in a significant expansion of the company’s over 3,000 points of retail distribution across the country. For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• Nug Avenue success provides healthy backdrop as SGMD looks ahead to opening new locations
• In addition to adding members, Nug Avenue has added new cannabis delivery technology to its format
• New delivery tech provides everything from route optimization to real-time delivery updates, saving time and money while producing higher customer satisfaction

Cannabis delivery continues to be a promising space in California — and around the country, for that matter— and the success of Sugarmade’s (OTC: SGMD) Nug Avenue firmly establishes the company as a leader in the growing sector (https://ibn.fm/IYCae). SGMD is leveraging the combination of Nug Avenue’s high performance and new delivery technology as it moves forward with expansion plans. “We have seen rapid and accelerating organic growth in customers at our initial Nug Avenue location since we opened the doors in March,” said Jimmy Chan, Sugarmade CEO. “The good news is that this trend survived reopening, with a reduction in pandemic-related measures and regulations having no impact on our growth. That provides a very healthy backdrop as we look ahead to opening new locations, upgrading our service and verticalizing our model through our own cultivation resources.” In a recent shareholder update, Chan noted that SGMD’s initial Nug Avenue hub, which is located in the Los Angeles metro area, has seen dramatic growth since opening its doors in March 2021. In fact, by the end of June 2021, it had gathered more than 10,000 unique members. That growth has only increased, reaching nearly 25,000 unique members in the company’s most recent report. In addition to adding members, SGMD’s Nug Avenue has added new cannabis delivery technology to its format. Nug Avenue now features the Onfleet last-mile delivery solution with Blaze, which is designed specifically to strengthen the company’s competitive advantage in its core delivery zone. According to the company Onfleet provides AI-based automated dispatch, automatic SMS customer notifications with accurate ETAs, real-time driver tracking, proof-of-delivery, feedback collection tools, and powerful analytics to ensure every delivery is an optimal experience. “The industry average is measured in hours when it comes to cannabis orders in the California delivery marketplace,” reported Chan, who noted that in the first month of adoption, Nug Avenue’s average delivery time decreased to 41.51 minutes, and customer satisfaction rose to 4.83 out of 5 stars on average. “We are working to shorten that window and gain an edge to drive market share gains. This technology provides everything from route optimization to real-time delivery updates, saving us time and money while producing higher customer satisfaction in the process. Given this information, SGMD’s plans to expand seem grounded in sound strategy. The company has already submitted all documentation for the opening of a second Nug Avenue location and is ready to take whatever additional action is required in order to officially open the new location. And that’s just the beginning. SGMD management is also looking for additional properties for further expansion, including outside of the LA marketplace. Expanding its Nug Avenue piece isn’t the only growth in Sugarmade’s future. The company is taking active steps toward the first planting at its subsidiary Lemon Glow, a large 640-acre outdoor cultivation sit. SGMD is waiting for the final go-ahead for the 2022 planting season. Sugarmade has set its eyes on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while also developing its in-house cannabis production capacity to verticalize operations in the space. Through a combination of organic growth and strategic acquisitions, Sugarmade is working to develop a full farm-to-door vertically integrated cannabis business. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush(TM), NUG Avenue, Lemon Glow and Budcars. For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

• Mydecine has partnered with Dr. Matthew Johnson and Johns Hopkins University for two upcoming trials for MYCO-001 – a psilocybin approach to smoking cessation
• The company is positioned to fill a billion-dollar hole in the industry after the leading pharmaceutical Chantix was removed from the market due to cancer risks
• Two previous psilocybin trials conducted by Dr. Johnson, show promising results for the use of psilocybin as a smoking cessation tool when paired with cognitive behavioral therapy (“CBT”)

Smoking remains among the leading public health concerns of the 21st century. The total number of tobacco-related deaths worldwide has reached six million, a figure expected to rise to eight million by 2030 (https://ibn.fm/RYhMD). Earlier this year, one of the leading smoking cessation tools prescribed by physicians, Chantix, was pulled off the market for its cancer risk, leaving a large hole in a fast-growing market rife with opportunity. Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a  biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, is in a good position to tap into the opportunities offered by this sector, which is expected to reach $63.99 billion by 2026, growing at a CAGR of 16.9% (https://ibn.fm/4ag0A). Mydecine has partnered with Dr. Matthew Johnson and Johns Hopkins University (“JHU”) to advance the company’s lead drug candidate MYCO-001 as a smoking cessation treatment. MYCO-001 is 99% pure psilocybin – a hallucinogenic alkaloid, which is often found in mushrooms. Positive clinical data has been produced assessing psilocybin and smoking cessation. In 2014, Johnson conducted a study of 15 participants that underwent cognitive behavior therapy (“CBT”) and used psilocybin. A total of 67% of the group had abstained from nicotine use at the clinical data’s 12-month mark. Again, in 2020, Johnson conducted a new smoking cessation study that showed promising results as well. This trial consisted of 100 participants who used a combination of a single dose psilocybin and CBT or the nicotine patch and CBT.  At the 12-month follow-up, the psilocybin treatment saw 59% abstaining from nicotine and 28% abstaining with the use of the patch. In 2022, Johnson will be conducting two clinical trials to assess the safety and efficacy of the Mydecine’s proprietary MYCO-001 for treating nicotine dependence. The company’s seamless phase 2/3 trial at JHU will run in conjunction with Dr. Matt Johnson’s multi-site NIDA (National Institute on Drug Abuse) grant-funded study taking place at Johns Hopkins University, New York University and University of Alabama Birmingham. The NIDA study marks the first time in 50 years the government has funded a study of a psychedelic compound for therapeutic use. To date, Mydecine is the only company sponsoring clinical trials that use psilocybin to treat nicotine dependence. At this rate, Mydecine has positioned itself to bring a safer, more effective treatment to market as early as 2024 (https://ibn.fm/5zTRm). Mydecine CEO Josh Bartch commented about upcoming trials in 2022 and discussed Johnson’s role in conducting these studies, as well as the C$5.5 million (US$4.2 million) financing the company received recently to fund its research (https://ibn.fm/pkCqK). “I would like to thank our incredible strategic shareholder for stepping up in a tough, volatile market and continuing to support and expand upon your large stake in Mydecine,” Bartch said. “This financing will give Mydecine the runway needed to continue meeting important milestones like launching our smoking cessation study in partnership with Johns Hopkins University and PTSD (Post Traumatic Stress Disorder) studies with various global military-focused organizations, furthering our drug development initiatives and growing paid subscribers on our telehealth platform Mindleap.” Bartch also underlined that he was proud of the company’s accomplishments to date and was looking forward to launching multiple clinical trials in early 2021. For more information, visit the company’s website at www.Mydecine.com. NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

• Enhanced graphics, VR, AR, cryptocurrency expected to fuel fast-growing iGaming industry
• PLGNF leverages technological innovation to provide B2B solutions for operators that deliver an authentic experience
• PLGNF platform currently hosts 26 operators, eight in integration & user acceptance testing (“UAT”) stage
• iGaming growth expected to reach $127.3 billion by 2027, CAGR of 11.94 percent

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF), a propriety SaaS technology company that delivers live dealer mobile technology to global online gaming operators, is on track to continue growing into 2022 by aligning with emerging technology trends outlined in a recent report (https://ibn.fm/raPVW). According to the report, technological innovation delivers enhanced graphics, virtual reality (“VR”), increased security, and cryptocurrency payment options that benefit the iGaming industry. PLGNF, with its proprietary cloud-based technology, offers operators turnkey solutions that leverage technological advancements to deliver authentic gaming experiences to a growing user base driven online by COVID-19 lockdown policies. Traditional games hosted in physical environments have mass appeal by blending visual and auditory elements that enhance the overall gaming experience. Today, technological innovation aims to duplicate that environment by replacing traditional games with RPG-themed versions, creating VR and AR environments, and offering live-dealer versions that deliver an element of social interaction to the iGaming experience. As a result, growth in iGaming is skyrocketing, projected to reach $127.3 billion by 2027 at a CAGR of 11.94 percent, according to Grandview Research (https://ibn.fm/jBZHB). Accordingly, as the industry grows, legislation is emerging with stricter rules that protect users, giving dozens of institutions and bodies the ability to regulate gambling platforms, issue licenses, and impose fines on operators engaging in malpractice. As a result, trust in the iGaming industry is expected to increase with expectations that enhanced regulation will attract more users to the platforms. PLGNF is in complete alignment with advancements in iGaming technology by providing a multitenant gateway that allows operators to deliver exciting gaming products on any device without sharing sensitive data or requiring an app store download. With 26 operators across four content aggregator clients in Europe and South Africa – and another eight operators at the UAT stage – the company’s cloud-powered platform is built to accommodate new demand easily. The company’s software is mobile-focused, device-agnostic, and built for one-handed play in portrait mode only. Current offerings include live-dealer table games broadcast from their state-of-the-art Las Vegas studio and a complimentary suite of eTable games based off their live versions. More games are in the development pipeline, with an expected release of an additional suite of games of both live and eTable versions in the near future, including craps, sicbo, hold ‘em poker, and 3-card poker. PLGNF is led by CEO Darcy Krogh – a pioneer in developing browser-based digital content for the iGaming market. Krogh is joined by CPO Guido Ganschow, who brings 13 years of experience creating real-time, live-dealer technology and platforms. Together they are joined by COO Steve Baker, a former executive of Shaw Communications who grew revenue from $300 million to $2.8 billion during his tenure as VP at the company (https://ibn.fm/2uhx6). With more than three decades of iGaming experience and multiple successful exits, PLGNF’s management team is positioning the company to lead the hyper-growth iGaming market with a mix of strategy, value, and alignment with technological innovation. For more information, visit the company’s website at www.Playgon.com. NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

• The podcast is hosted by Executive Coach and Speaker Sergio Tigera, who spent half an hour discussing Anstey’s cryptocurrency past, present, and future
• The LQwD CEO shared his unique perspective on the journey, mindset, struggles, and successes accomplished
• The PaaS offered by LQwD was released November 17 and makes Bitcoin’s Lightning Network easy to use and allowing for low fees, faster transactions and the ability to make micro-transactions

The December 21 episode of Gamechangers LIVE(R) featured the Co-Founder, Chairman, and CEO of LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), Shone Anstey. LQwD is a fintech company that focuses on creating enterprise-grade infrastructure to drive Bitcoin adoption. The Gamechangers LIVE podcast is a series that puts a spotlight on individuals who are game-changers in their respective fields or industry. During the podcast, Anstey was able to share a unique perspective on the journey, mindset, struggles, and successes accomplished – all to inspire and inform Gamechangers LIVE(R) listeners (https://ibn.fm/fJvRM). Executive Coach and Speaker Sergio Tigera hosted the Gamechangers LIVE(R) podcast. During the interview, Anstey talked about his background in the cryptocurrency industry, including his co-founding of BIGG Digital Assets (CSE: BIGG) (OTCQX: BBKCF), and then turned his attention to the Lightning Network. “I started BIGG Digital Assets late in 2014. We went through crypto winter, survived all of that, came out the other side, and built a great compliance software. In 2019, we bought Netcoins and bolted on our compliance software to create a compliance-first exchange,” Anstey said, underlining that BIGG has now become one of Canada’s largest exchanges. “I’m still with BIGG as a director and large shareholder, but my full-time focus has been on LQwD for the past two years.” After discussing his BIGG venture, Anstey discussed the Lightning Network and LQwD’s overlay for the network, which is designed to improve the overall transactional process. “When Bitcoin came around, it just was like ‘hey, this is just an extension of the internet.’ Everything that we’re doing here is just a continuation of the revolution of the internet. I came from an analytics background. I’m a pragmatic person. I was looking at how to take Bitcoin mainstream and how to take crypto mainstream,” Anstey explained his approach and motivation during the interview. The LQwD CEO offered some of his own insight into Bitcoin’s Lightning Network, the benefits it provides, and its future. “The Lightning Network solves Bitcoin’s scalability issue. At seven transactions per second, Bitcoin is very slow and very secure. If you want to transfer $100 million worth of Bitcoin, the main network is absolutely acceptable, but if you want to use Bitcoin every day for coffee or purchases or remittances of smaller denominations, the Lightning Network allows you to send really small amounts more quickly. It offers a real solution to the scaling problem,” he said. Anstey added that the Lightning Network has been experiencing rapid growth over the last five years, with a 205% increase of the network in terms of nodes, channels, and capital this year alone. The largest point that Anstey made during the interview with Tigera focused on the benefits and scalability of Bitcoin’s Lightning Network. LQwD has leveraged these features, using the advantages of the Lightning Network and the necessity of a scalable solution for remitting smaller payments more quickly, which is where the company’s platform-as-a-service (PaaS), lqwd.tech, factors in. LQwD’s PaaS was released earlier last month, November 17, offering an alternative to the traditional blockchain transactions – the Lightning Network offers fewer fees, quicker transaction settlements, and transaction security. LQwD’s PaaS aims to empower institutions, businesses, and investors making the Lightning Network easy to work with, lqwd.tech was designed to be scalable and adaptive to the fast-paced growth of the Network, allowing for millions of Bitcoin transactions in seconds. LQwD expects that the Lightning Network will be a force for change globally and become the global monetary exchange of the future. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• The point-of-care testing market is projected to be valued at $81.37 billion by 2028, representing a CAGR of 9.4% over the forecast period (2020-2028)
• Avricore plans to capitalize on this growth through investing in its technology and forging strategic partnerships that bring its services closer to patients
• For the 2021 calendar year, Avricore partnered with Shoppers Drug Mart pharmacy to pilot its HealthTab(TM) platform in specific locations
• Having capitalized and executed several critical agreements for 2021, the company is confident that it is well-positioned for growth in 2022

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator, has remained focused on acquiring and developing early-stage tech, intending to move pharmacy forward. Its flagship offering, HealthTab(TM), seeks to offer turnkey point-of-care testing solutions, so far covering key ailments such as diabetes, cardiovascular conditions, and Covid-19. Avricore’s goal is to reach as many people as possible, and one way it is planning to achieve this is by partnering with community pharmacies. By equipping these drugstores with their state-of-the-art Afnion 2(TM) analyzers provided by Abbott Rapid Diagnostics, patients can get results in less than 10 minutes. This allows them to spend more time improving their health and less time waiting around for test results, as was previously the case. So far, in the 2021 calendar year, Avricore has partnered with Shoppers Drug Mart pharmacies to pilot the HealthTab platform in specific locations (https://ibn.fm/NMZ6v). The success of their partnership has shown the platform’s potential and the value that it brings, not just to patients but also to the company. As Avricore works towards being the world’s largest health diagnostics solutions provider, strategic partnerships with community pharmacies have proven to be integral to achieving this goal. It is projected that by 2028, the global point-of-care testing (“POCT”) market will be valued at $81.37 billion, up from $34.49 billion in 2020. This will represent a compound annual growth rate (“CAGR”) of 9.4%, primarily driven by the increased demand for screening and management tools for chronic diseases, coupled with the rapid assessment of infectious diseases such as Covid-19 (https://ibn.fm/kjJ8G). Avricore recognizes this opportunity, hence its investment in its technology and forging strategic partnerships that bring it even closer to patients, including those in rural areas. Going into 2022, the company is confident that it will realize strong growth given its milestones over the 2021 calendar year. “We’ve had our best year yet, despite many external factors that created headwinds, and we’re extremely excited to head into 2022,” noted Hector Bremner, the Chief Executive Officer (“CEO”) of Avricore. “Given that we are well capitalized and have executed several key agreements already, we’re well positioned for growth,” he added (https://ibn.fm/3mYf7). Avricore promises to help patients and create value for its shareholders, one community pharmacy at a time, a critical factor that will contribute to its growth for the 2022 calendar year. For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

• USPTO notice marks important milestone in the expansion of CYBN’s intellectual property portfolio
• Once issued, patent may have opportunity to cover a broad range of claims
• Anxiety disorders are one of the most common mental illnesses in the United States

Cybin (NEO: CYBN) (NYSE American: CYBN) has taken another step forward in its commitment to progressing Psychedelics to Therapeutics(TM). The biopharmaceutical company has received a notice of allowance from the U.S. Patent and Trademark Office (“USPTO”) in regard to its patent application connected to its investigational deuterated psychedelic tryptamine compound for the potential treatment of anxiety disorders (https://ibn.fm/fpjXm). “The receipt of this notice of allowance from the USPTO represents an important milestone in expanding our intellectual property portfolio progressing psychedelics to therapeutics for the countless patients in need, and strongly demonstrates the company’s dedication to the discovery and development of differentiated psychedelic-based compounds for addressing mental health,” said Cybin CEO Doug Drysdale. “Once issued, this patent may have the opportunity to cover a broad range of claims supporting our IP in psychedelic medicine and further strengthen our emerging best-in-class position in this evolving industry.” Cybin applied for the patent to study CYB004, its proprietary psychedelic tryptamine compound with the potential to effectively treat anxiety disorders without the common side effects associated with current treatments. The potential for this sector is significant, as anxiety disorders are one of the most common mental illnesses in the United States. Based on reports from the U.S. National Institute of Mental Health, an estimated 40 million adults, or approximately 18% of the population, deal with anxiety disorders. And while many treatments are available, the success of these treatments is underwhelming, with up to 50% of patients with general anxiety disorder failing to respond to first-line treatments. In addition, “current standardized treatments for anxiety disorders also require chronic administration of medicines that have a long time to onset and present several potential side effects including weight gain, gastrointestinal disturbances, sexual dysfunction and withdrawal symptoms,” the company reports. Cybin hopes to solve many of these issues with its CYB004 compound, as well as other compounds it is developing. The USPTO note of allowance includes other forms of deuterated psychedelic tryptamine, the announcement reported, including certain deuterated forms of CYBN’s DMT and 5-MeO-DMT formulations. A leading ethical biopharmaceutical company, Cybin is working with a network of world-class partners and internationally recognized scientists to create safe and effective therapeutics for patients to address a multitude of mental health issues. The company operates in the United States, the United Kingdom and Ireland. The company is focused on progressing psychedelics to therapeutics by engineering proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• Global supply chain disruptions are set to spread to the North American cannabis market
• Supply shortages are already being felt in the manufacture of vaping devices and specialty packaging with rising concerns that these could extend to raw cannabis flower supply
• American Cannabis Partners has distinguished itself through both a strict focus on a vertically integrated business model as well as through its adherence to unique Jamaican cultivation techniques
• The company now has plans to expand operations to a third state in 2022 and a fourth state by 2024

A shortage of Nutella and new automobiles, higher gas prices, and delayed deliveries on Christmas presents can all be linked to ongoing and major disruptions in the global supply chain. However, and in a largely unforeseen twist, shortages have now extended to the North American cannabis market. Rolling power outages in China, incessant shipping disruptions and the upcoming Chinese Lunar New Year holiday are increasingly set to play havoc on the global cannabis supply chain. The shortages and resulting impact on cannabis supply has led to a greater premium being placed on vertically integrated producers, with American Cannabis Partners (“ACP”) — a multi-state 100% organic cannabis cultivation company headquartered within Northern California’s Emerald Triangle — a key proponent of the business model. A recent survey delving into vaporizer use among cannabis consumers in the United States found that 37% of respondents had reported vaping cannabis in the past 30 days, with respondents revealing that they found the experience to be healthier, better tasting, producing better effects, and generally more satisfying in nature (https://ibn.fm/eKiCN). However and in a recent interview with New York-based vaping device manufacturer, Blinc Group, the company’s Chief Executive stated that they were finding increasing supply shortages in six of the 13 components which went into vape hardware, with disruptions and delays set to intensify ahead of the onset of the Lunar New Year holiday (https://ibn.fm/ODmL2). “I believe this issue will go on at least until the end of May [2022],” stated Blinc Group CEO Dumas de Rauly. “[However] it is not just vape devices. The raw material for the equipment that fills them with cannabis, the LEDs for the grow houses — all of it comes from China.” The cannabis industry has been shielded from supply-chain woes thus far, largely due to its hyper-local nature. As it is still classed as a Schedule I substance, companies risk legal imbroglios unless they grow and process the plant in the state where it will be sold. While most companies have thus far only suffered from shipping delays on items such as vape cartridges and specialty packaging, they believe it is only a matter of time until shortages start to affect the raw cannabis product itself. “We’re trying to order ahead — we’re not paying more [yet], but we’re paying up front; also, we’ve begun to source domestic pools of inventory,” said Josh Krane, vice president of operations for 4Front Ventures, a US-based cannabis multi-state operator. Since its founding in 2018, American Cannabis Partners has sought to establish a foothold in two key U.S. cannabis markets — California and Michigan, through a sustainable, vertically-integrated model. Since inception, the company has acquired 12 cannabis licenses, including 20,000 sq. ft. of cultivation licenses in California and 540,000 sq. ft. of cultivation licenses and one retail license in Michigan. The company currently supplies approximately 80% of its whole flower product to third-party manufacturers and distributors; the remaining 20% is used in the manufacture and sale of its exclusive in-house brand, ZÜK. In addition to its self-sustaining model, American Cannabis Partners has sought to differentiate its product within an increasingly commoditized cannabis market through the company’s unique adherence to Jamaican cultivation practices, which has led the company to produce some of the most sought-after flowers in the United States. In fact, and following its most recent harvest, ACP revealed that it has already seen its new, patent pending strains marketed under their ZÜK brand, presold for 2021 (https://ibn.fm/QWO7L). (https://ibn.fm/K4ez5). As a result of its strict focus on acquiring its own real estate and their vertically integrated model, American Cannabis Partners now finds itself in an enviable position to expand into its third U.S. state in 2022 and its fourth in 2024 (https://ibn.fm/GZZoC). (https://ibn.fm/FhwhC). With the U.S. cannabis market set to touch a forecasted annual value of $115 billion by 2030 according to investment bank Piper Sandler (https://ibn.fm/Ygilv), ACP finds itself in an enviable position to grow and develop their business at a time when the rest of the industry finds itself subject to the vagaries of the global supply chain. For more information, visit the company’s website at www.ACPFarms.com. NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://ibn.fm/ACP